# Sarepta Therapeutics, Inc.: Form 8-K, filed Mar 3, 2023

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2023-03-03
- Accepted by EDGAR: Mar 3, 2023, 07:31 ET
- Period: 2023-03-02
- Accession: 0001193125-23-058990
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/d478993d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/d478993d8k.htm

Filed Mar 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-058990. Last ingested by Listed: Nov 14, 2026, 19:58 ET. No prices; not investment advice.
